Drug Information

Drug General Information
Drug ID
D0VN8V
Former ID
DNC010112
Drug Name
4-[2-(4-Benzylphenoxy)ethyl]pyridine
Drug Type
Small molecular drug
Indication Discovery agent Investigative [530549]
Formula
C20H19NO
Canonical SMILES
C1=CC=C(C=C1)CC2=CC=C(C=C2)OCCC3=CC=NC=C3
InChI
1S/C20H19NO/c1-2-4-18(5-3-1)16-19-6-8-20(9-7-19)22-15-12-17-10-13-21-14-11-17/h1-11,13-14H,12,15-16H2
InChIKey
PHONRHOSBJCBIH-UHFFFAOYSA-N
PubChem Compound ID
44818625
Target and Pathway
Target(s) Leukotriene A-4 hydrolase Target Info Inhibitor [530549]
BioCyc Pathway Leukotriene biosynthesis
KEGG Pathway Arachidonic acid metabolism
Metabolic pathways
PathWhiz Pathway Arachidonic Acid Metabolism
WikiPathways Arachidonic acid metabolism
Eicosanoid Synthesis
References
Ref 530549J Med Chem. 2010 Jan 28;53(2):573-85.Discovery of 4-[(2S)-2-{[4-(4-chlorophenoxy)phenoxy]methyl}-1-pyrrolidinyl]butanoic acid (DG-051) as a novel leukotriene A4 hydrolase inhibitor of leukotriene B4 biosynthesis.
Ref 530549J Med Chem. 2010 Jan 28;53(2):573-85.Discovery of 4-[(2S)-2-{[4-(4-chlorophenoxy)phenoxy]methyl}-1-pyrrolidinyl]butanoic acid (DG-051) as a novel leukotriene A4 hydrolase inhibitor of leukotriene B4 biosynthesis.